跳至主要内容
临床试验/NCT00972946
NCT00972946已完成不适用

The Use of Magnetic Resonance Imaging and Superparamagnetic Particles of Iron Oxide in Cardiovascular Disease - a Pilot Study in Healthy Volunteers

University of Edinburgh1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Change in signal intensity in the region of interest on MRI scanning

研究概览

简要总结

The ability to label specific cells and image their natural movements in vivo would allow researchers to investigate the mechanisms of disease progression. In addition, cell-based therapy, especially stem cell therapy, requires non-invasive monitoring of transplanted cells to follow their bio-distribution and biological function. Because of recent interest in stem cell treatment, several methods have been investigated for in vivo cell tracking. The investigators propose to assess whether the magnetic resonance imaging (MRI) contrast agent Endorem (superparamagnetic particles of iron oxide) can be used to label cells for in vivo tracking using MRI. The investigators will use 20 healthy human volunteers to:

  1. Assess the feasibility of imaging Endorem-labelled cells in vivo
  2. Compare the distribution of Endorem-labelled cells with that of intravenous injection of Endorem

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers
  • Age >18 years

排除标准

  • Pregnancy
  • Contraindication to MRI scanning (detected by safety questionnaire) including severe claustrophobia
  • Inability or refusal to give informed consent
  • Renal or hepatic dysfunction
  • HIV/hepatitis B/ hepatitis C/ HTLV/ syphilis
  • Intercurrent illness
  • Blood dyscrasias

研究组 & 干预措施

Administration of labelled cells

Experimental

MRI scanning before and after administration of iron-labelled cells

干预措施: Administration of autologous Endorem-labelled mononuclear cells intravenously (Biological)

Administration of Endorem

Experimental

MRI scanning before and after intravenous administration of Endorem

干预措施: Administration of Endorem (Drug)

结局指标

主要结局

Change in signal intensity in the region of interest on MRI scanning

时间窗: 0 hours, 24 hours, 48 hours, 5-7 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Cell Tracking Using Superparamagnetic Particles of... | 临床试验